SpringWorks Therapeutics Files 8-K on Shareholder Votes
| Field | Detail |
|---|---|
| Company | Springworks Therapeutics, Inc. |
| Form Type | 8-K |
| Filed Date | Jun 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: SWTX
TL;DR
SWTX filed an 8-K for shareholder votes on 6/26. Standard governance stuff.
AI Summary
SpringWorks Therapeutics, Inc. filed an 8-K on June 26, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about the votes or outcomes, but it serves as an official record of the company's corporate governance activities.
Why It Matters
This filing indicates that SpringWorks Therapeutics held a shareholder meeting where votes were cast on corporate matters, a standard but important part of public company operations.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for a corporate event (submission of matters to a vote) and does not indicate any new financial or operational risks.
Key Players & Entities
- SpringWorks Therapeutics, Inc. (company) — Registrant
- June 26, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 100 Washington Blvd Stamford, Connecticut 06902 (address) — Principal executive offices
- 203-883-9490 (phone_number) — Registrant's telephone number
FAQ
What specific matters were submitted to a vote of SpringWorks Therapeutics' security holders?
The filing states that it is a 'Submission of Matters to a Vote of Security Holders' but does not detail the specific proposals or resolutions voted upon in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 26, 2025.
What is the exact name of the registrant filing this report?
The exact name of the registrant is SpringWorks Therapeutics, Inc.
In which state was SpringWorks Therapeutics, Inc. incorporated?
SpringWorks Therapeutics, Inc. was incorporated in Delaware.
What is the principal executive office address for SpringWorks Therapeutics, Inc.?
The principal executive office address is 100 Washington Blvd, Stamford, Connecticut 06902.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 26, 2025 regarding SpringWorks Therapeutics, Inc..